Development and Validation of an Explainable Machine Learning Model for Prediction of Massive Transfusion in Upper
Zixi Lin1, Hailiang Zhao2, Yilong Hu3
1Department of Blood Transfusion, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, People's Republic of China.
Risk Management and Healthcare Policy
|March 25, 2026
Summary
We developed an explainable machine learning model to predict massive transfusion in upper gastrointestinal bleeding (UGIB) patients, improving accuracy over traditional scores. This tool aids in early identification of high-risk patients for better blood management.
Area of Science:
- Medical research
- Clinical informatics
- Machine learning applications in healthcare
Background:
- Upper gastrointestinal bleeding (UGIB) is a critical condition with high mortality, particularly when massive transfusion (MT) is needed.
- Existing scoring systems for MT prediction in UGIB have moderate accuracy and do not fully capture complex variable interactions.
Purpose of the Study:
- To develop and validate an explainable machine learning (ML) model for predicting the need for MT in patients with UGIB.
- To improve the precision and interpretability of MT risk assessment in UGIB compared to traditional methods.
Main Methods:
- A retrospective study involving 700 UGIB patients, with data split into training, testing, and external validation cohorts.
- Feature selection using Boruta and LASSO regression identified 8 key clinical variables from an initial 18.
- Seven ML algorithms were evaluated, with the optimal model further assessed for discrimination, calibration, and clinical utility using SHapley Additive exPlanations (SHAP) for interpretability.
Main Results:
- The Random Forest (RF) model demonstrated superior performance with high AUC values across training (0.862), testing (0.823), and external validation (0.807) cohorts.
- Calibration plots confirmed strong agreement between predicted and observed probabilities, and decision curve analysis showed clinical utility.
- SHAP analysis identified key predictors such as impaired mental status, liver cirrhosis, and INR, aligning with clinical expertise.
Conclusions:
- The developed ML model shows significant promise for accurately identifying UGIB patients at high risk of requiring MT.
- The model's interpretability enhances its potential to assist clinicians in optimizing blood management strategies.
- Further prospective validation is recommended to confirm the model's clinical utility in diverse healthcare settings.
Related Concept Videos
Blood Transfusion
2.9K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.9K
Blood Transfusion and Agglutination
15.6K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.6K


